Cassava Sciences | PTIE - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Abbott USD 29.64B 19.74B 2026-03
Amgen USD 51.89B 1.88B 2026-03
Biogen USD 6.29B 1.7M 2026-03
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Eisai JPY 134.77B 12M 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Geron USD 119.55M 283K 2025-12
J&J USD 37.53B 1.91B 2026-03
Merck USD 46.67B 77M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Novavax USD 246.3M 200K 2025-12
Pfizer USD 60.57B 1.08B 2026-03
Roche Holding CHF 27.43B 966M 2025-12